Primum non nocere: allo-HSCT for AML in CR1

Blood. 2021 Jan 28;137(4):438-439. doi: 10.1182/blood.2020008641.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adult
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Leukemia, Myeloid, Acute* / therapy
  • Receptors, Complement 3b

Substances

  • CR1 protein, human
  • Receptors, Complement 3b